Clinical Trials Browser

Withdrawn × Esophageal Neoplasms × Radiation × Clear all

NCT02716688 2023-09-22

S-1 and Radiotherapy for Elderly Esophageal Cancer Patients

Phase 2 Withdrawn

Gastrointestinal

Esophageal Neoplasms

NCT03220009 2018-10-03

Nivolumab or Expectant Observation Following Ipilimumab, Nivolumab, and Surgery in Treating Patients With High Risk Localized, Locoregionally Advanced, or Recurrent Mucosal Melanoma

Phase 2 Withdrawn

DermatologicGastrointestinalGynecologic

Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Vaginal Neoplasms, Vulvar Neoplasms